Dialysis AccessPatented
Flow-control AV graft
A dialysis-access graft designed to limit excessive continuous access flow — and the cardiac burden that comes with it — while supporting dialysis. A VascX platform.
Clot and embolic protection, dialysis access, and revascularization — engineered around the procedures clinicians perform every day.
From the clots and emboli that threaten hospitalized and high-risk patients, to the high-flow burden and access failures of dialysis, Principal Medical takes on vascular problems where today's devices still fall short — and redesigns them around the patient.
Each program begins with a procedure clinicians know well — and a device that hasn't kept up with it.
A portfolio spanning embolic protection, thrombectomy, dialysis access, and peripheral revascularization — each in development, each redesigned around the patient.
A dialysis-access graft designed to limit excessive continuous access flow — and the cardiac burden that comes with it — while supporting dialysis. A VascX platform.
An endovascular stent intended to introduce flow control to existing fistulas and grafts, without open surgery. A VascX platform.
A tethered, fully retrievable IVC filter for temporary PE protection — designed to avoid the fracture, migration, and non-retrieval risks of permanent filters. For ICU and intraprocedural use.
A catheter-clearance platform intended to help restore function to occluded dialysis catheters through a closed, ready-to-use system.
A hemodynamically optimized lower-extremity bypass graft, with return-limb technology designed to maintain outflow in the low-flow conditions where standard grafts fail.
A mechanical thrombectomy device that captures the clot in a net and removes it whole — designed to spare the vein wall and valves the trauma of conventional techniques.
Up to 70% of permanent IVC filters are never retrieved — a leading source of downstream complications. AngioShield is designed for temporary protection: a tethered, single-wire filter that goes in through a 4F sheath and comes out cleanly at the bedside.
Built with the clinicians who use them.
Principal Medical develops devices across embolic protection, thrombectomy, dialysis access, and revascularization. Some improve on procedures clinicians perform every day; others are entirely new. Each begins with a practicing vascular specialist and a problem worth solving.
Updates from Principal Medical and its programs.
Coverage of the VascX flow-control platform, developed by Principal Medical's dialysis-access subsidiary.
Read at vascx.com →Principal Medical continues to develop its portfolio of vascular and dialysis-access technologies across the pipeline.
Get in touch →We welcome inquiries from clinicians, partners, and investors interested in the portfolio.
Get in touch →Detail on each technology in the Principal Medical portfolio.
We welcome inquiries from clinicians, researchers, investors, and potential partners interested in the Principal Medical portfolio.